Population pharmacokinetic-pharmacodynamic modeling of TF-505 using extension of indirect response model by incorporating a circadian rhythm in healthy volunteers

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 8, 2005, Pages 1455-1461

  Matsumoto, Yoshiaki ^a,d   Fujita, Tomoe ^b   Ishida, Yoshimasa ^a   Shimizu, Makiko ^a   Kakuo, Hiroyuki ^c   Yamashita, Kazumasa ^c   Majima, Masataka ^b   Kumagai, Yuji ^b  

^a SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TAIHO PHARMACEUTICAL CO LTD   (Japan)

^d NIHON UNIVERSITY   (Japan)

Author keywords

Chronopharmacologic rhythm; NONMEM; Pharmacokinetic pharmacodynamic modeling; Population; TF 505

Indexed keywords

4 [1 [4 [1 (4 ISOBUTYLPHENYL)BUTOXY]BENZOYL]INDOLIZIN 3 YL]BUTYRIC ACID; ANDROSTANOLONE; STEROID 5ALPHA REDUCTASE INHIBITOR; TF 505; UNCLASSIFIED DRUG;

ARTICLE; CHRONOPHARMACOLOGY; CIRCADIAN RHYTHM; DRUG DOSE REGIMEN; HUMAN; HUMAN EXPERIMENT; MALE; MODEL; NORMAL HUMAN; PHARMACODYNAMICS;

ADULT; CIRCADIAN RHYTHM; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INDOLIZINES; MALE; MODELS, BIOLOGICAL; POPULATION SURVEILLANCE;

EID: 25644455929     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.1455     Document Type: Article

References (27)

1. Thigpen A. E., Silver R. I., Guileyardo J. M., Casey M. L., McConnell J. D., Russell D. W., J. Clin. Invest., 92, 903-910 (1993).
2. Brendler C. B., Follansbee A. L., Isaacs J. T., J. Urol., 133, 495-501 (1985).
3. Bruchovsky N., Rennie P. S., Batzold F. H., Goldenberg S. L., Fletcher T., McLoughlin M. G., J. Clin. Endocrinol. Metab., 67, 806-816 (1988).
4. Hudson R. W., Wherrett D. J., Steroid Biochem., 35, 231-236 (1990).
5. Andersson S., Berman D. M., Jenkins E. P., Russell D. W., Nature (London), 354, 159-161 (1991).
6. Imperato-McGinley J., Guerrero L., Gautier T., Peterson R. E., Science, 186, 1213-1215 (1974).
7. Fujita T., Matsumoto Y., Kimura T., Yokota S., Sawada M., Majima M., Ohtani Y., Kumagai Y., Br. J. Clin. Pharmacol., 54, 283-294 (2002).
8. Beal S. L., Sheiner L. B., "NONMEM Users' Guide," NONMEM Project Group, University of California, San Francisco, 1988.
9. Sjoberg B., de la Torre B., Hedman M., Falkay G., Diczfalusy E., J. Endocrinol. Invest., 2, 131-137 (1979).
10. Guignard M. M., Pesquies P. C., Serrurier B. D., Merino D. B., Reinberg A. E., Acta Endocrinol., 94, 536-545 (1980).
11. Zhou H., Choi L., Lau H., Bruntsch U., Vries E. E., Eckhardt G., Oosterom A. T., Verweij J., Schran H., Barbet N., Linnartz R., Capdeville R., J. Clin. Pharmacol., 40, 275-283 (2000).
12. Schmith V. D., Fiedler-Kelly J., Phillips L., Grasela T. H., Jr., Pharm. Res., 14, 91-97 (1997).
13. Williams P. J., Lane J. R., Turkel C. C., Capparelli E. V., Dziewanowska Z., Fox A. W., J. Clin. Pharmacol., 41, 259-267 (2001).
14. Zannikos P. N., Rohatagi S., Jensen B. K., DePhillips S. L., Rhodes G. R., J. Clin. Pharmacol., 40, 1129-1140 (2000).
15. Cullberg M., Eriksson U. G., Larsson M., Karlsson M. O., Br. J. Clin. Pharmacol., 51, 71-79 (2001).
16. Ploeger B., Mensinga T., Sips A., Deerenberg C., Meulenbelt J., DeJongh J., Toxicol., Appl. Pharmacol., 170, 46-55 (2001).
17. Guan F., Ishii A., Seno H., Watanabe-Suzuki K., Kumazawa T., Suzuki O., Anal. Chem., 71, 4034-4043 (1999).
18. Hosaka M., Konno M., Mamiya T., Nishimura R., Makino T., Folia. Endocrinol. Jap., 49, 1391-1393 (1973).
19. Jusko W. J., Ko H. C., Clin. Pharmacol. Ther., 56, 406-419 (1994).
20. Wyska E., Jusko W. J., Semin. Perinatol., 25, 124-132 (2001).
21. Katashima M., Irino T., Shimojo F., Kawamura A., Kageyama H., Higashi N., Miyao Y., Tokuma Y., Hata T., Yamamoto K., Sawada Y., Iga T., Clin. Pharmacol. Ther., 63, 354-366 (1998).
22. Ebling W. F., Matsumoto Y., Levy G., Pharm. Res., 13, 1804-1810 (1996).
23. Chakraborty A., Krzyzanski W., Jusko W. J., J. Pharmacokinet. Biopharm., 27, 23-43 (1999).
24. Gisleskog P. O., David H., Hammarlund-Udenaes M., Karlsson M. O., Clin. Pharmacol. Ther., 64, 636-647 (1998).
25. Tian G., Mook R. A., Jr., Moss M. L., Frye S. V., Biochemistry, 34, 13453-13459 (1995).
26. Ko H. C., Jusko W. I., Pharmacotherapy, 15, 509-511 (1995).
27. Vozeh S., Steimer J. L., Rowland M., Morselli P., Mentre F., Balant L. P., Aarons L., Clin. Pharmacokinet., 30, 81-93 (1996).